Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy

In order to track the evolution of primary protease inhibitor (PI) resistance mutations in human immunodeficiency virus type 1 (HIV-1) isolates, baseline and follow-up protease sequences were obtained from patients undergoing salvage PI therapy who presented initially with isolates containing a sing...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Kantor, Rami, Fessel, W. Jeffrey, Zolopa, Andrew R., Israelski, Dennis, Shulman, Nancy, Montoya, Jose G., Harbour, Michael, Schapiro, Jonathan M., Shafer, Robert W.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127108/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11897594/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.4.1086-1092.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!